Nanologica AB (4YD) Stock Statistics & Valuation Metrics

Nanologica AB has a market cap or net worth of €10.98M. The enterprise value is €53.87M.

Nanologica AB has 294,524,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Nanologica AB’s return on equity (ROE) is -2.26 and return on invested capital (ROIC) is -64.64%.

The current PE Ratio of Nanologica AB is ―. Nanologica AB’s PEG ratio is 0.02.

In the last 12 months, Nanologica AB had revenue of 21.13M and earned -51.29M in profits. Earnings per share was -0.58.

In the last 12 months, operating cash flow was -39.88M and capital expenditures -999.00K, giving a free cash flow of -40.88M billion.

Nanologica AB pays an annual dividend of ―, resulting in a dividend yield of ―

Nanologica AB upcoming earnings date is May 20, 2026, TBA (Confirmed).

Nanologica AB as a current ratio of 1.85, with Debt / Equity ratio of 95.72%

In the past 12 months, Nanologica AB has paid 0.00 in taxes.

Nanologica AB EV to EBITDA ratio is -2.51, with an EV/FCF ratio of -2.12.

Nanologica AB has €3.55M in cash and marketable securities with €21.68M in debt, giving a net cash position of -€18.13M billion.

Gross margin is -106.49%, with operating margin of -222.43%, and net profit margin of -242.77%.

The average price target for Nanologica AB is ―, which is 11.43% higher than the current price. The consensus rating is ―